The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway.
Noren NK; Foos G; Hauser CA; Pasquale EB; Nature Cell Biology, 2006, vol. 8, issue 8, p 815, ISSN 14657392. ISBN 14657392.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef